IDEXX Laboratories Aktie
437,42USD | -4,17USD | -0,94% |
WKN: 888210 / ISIN: US45168D1046
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 9 300 | 10 350 | 10 780 | 11 000 | 11 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,29 | 0,31 | 0,31 | 0,33 | 0,35 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 013 | 900 | 1 044 | 1 441 | 1 338 |
Summe Anlagevermögen | 1 281 | 1 537 | 1 703 | 1 819 | 1 955 |
Summe Aktiva | 2 295 | 2 437 | 2 747 | 3 260 | 3 293 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 1 662 | 1 747 | 2 138 | 1 775 | 1 698 |
Summe Eigenkapital | 633 | 690 | 609 | 1 485 | 1 595 |
Summe Passiva | 2 295 | 2 437 | 2 747 | 3 260 | 3 293 |
Adresse
One IDEXX Drive, 04092-2040 Westbrook | |
Telefon | +1 (207) 556-0300 |
Fax | +1 (207) 556-4346 |
Internet | http://www.idexx.com |
Management
Andrew Emerson
Chief Financial Officer, Treasurer & EVP |
Brian Patrick McKeon
Executive Vice President |
Bruce L. Claflin
Independent Director |
Daniel M. Junius
Independent Director |
George J. Fennell
Chief Revenue Officer & Senior Vice President |
Irene Chang Britt
Independent Director |
Jeffery Donn Chadbourne
SVP-Commercial Finance & Sales Operations |
John Hart
Senior Vice President-Global Operations |
John Ravis
Investor Relations Contact |
Jonathan J. Mazelsky
President, Chief Executive Officer & Director |
Ken Grady
Chief Information Officer & Senior VP |
Kerry Bennett
SVP, GM-Product, Strategy & Global Reference Labs |
Lawrence D. Kingsley
Non-Executive Chairman |
M. Anne Szostak
Independent Director |
Martin Alexander Smith
Chief Technology Officer & Executive VP |
Michael Erickson
EVP & GM-Point of Care Diagnostics & Telemedicine |
Michael J. Lane
Executive VP, GM-Reference Laboratories & IT |
Michael P. Johnson
Chief Human Resources Officer & Executive VP |
Michael Schreck
EVP, GM-Corporate Accounts & Customer Experience |
Murthy Yerramilli
Senior Vice President-Research & Development |
Sam A. Samad
Independent Director |
Sharon E. Underberg
Secretary, Executive VP & General Counsel |
Sophie V. Vandebroek
Independent Non-Executive Director |
Stuart M. Essig
Independent Director |
Tina Hunt
Executive Vice President-Strategy |